Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-296
Closed -$7.83K – 8406
2026
Q1
$7.83K Buy
+296
New +$37.5K ﹤0.01% 7021
2025
Q4
– Hold
0
– – – 8186
2025
Q3
– Hold
0
– – – 8150
2025
Q2
– Hold
0
– – – 7342
2025
Q1
– Hold
0
– – – 6825
2024
Q4
– Hold
0
– -$4 – 7967
2024
Q3
– Hold
0
– – – 7891
2024
Q2
– Hold
0
– – – 7490
2024
Q1
– Hold
0
– – – 7354
2023
Q4
– Hold
0
– – – 7283
2023
Q3
– Hold
0
– – – 7317
2023
Q2
– Hold
0
– – – 7348
2023
Q1
– Hold
0
– – – 7304
2022
Q4
– Hold
0
– – – 7395
2022
Q3
– Hold
0
– – – 7240
2022
Q2
– Hold
0
– – – 7175
2022
Q1
– Hold
0
– -$23K – 7941
2021
Q4
– Hold
0
– – – 7157
2021
Q3
– Hold
0
– – – 7590
2021
Q1
– Hold
0
– -$254K – 7474
2020
Q4
– Hold
0
– – – 5470

Morgan Stanley's ADTX Position: Q2 2026 in Review

Morgan Stanley sold out of Aditxt (ADTX) in Q2 2026, closing a stake of 296 shares — an estimated $7.83K sold.

Morgan Stanley first reported a position in ADTX in Q1 2026 and held it in 1 quarter. The position peaked at $7.83K in Q1 2026. 1 fund tracked by Wall St. Rank holds ADTX as of Q2 2026.

  • Morgan Stanley reported no remaining Aditxt position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 296 Aditxt shares in Q2 2026, an estimated $7.83K.
  • Morgan Stanley first reported a position in Aditxt in Q1 2026 and held it in 1 quarter.
  • Morgan Stanley's Aditxt position peaked at $7.83K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Aditxt as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.